All Stories

  1. Developing a national triage tool for use in NHS regional trauma networks: the MATTS mixed methods study

    Article • Health Technology Assessment, May 2026, National Institute for Health Research

    Mr Daniel J Pollard

  2. Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group

    Article • PharmacoEconomics, February 2026, Springer Science + Business Media

    Mr Daniel J Pollard

  3. Precision nutrition must consider cost-effectiveness to deliver benefits to patients

    Article • Nature Medicine, February 2026, Springer Science + Business Media

    Mr Daniel J Pollard

  4. My Diabetes & Me: study protocol for a randomised controlled trial to test the clinical and cost-effectiveness of a diabetes self-management education programme for adults with intellectual disabilities.

    Article • NIHR Open Research, October 2025, National Institute for Health Research

    Mr Daniel J Pollard

  5. Potential cost-effectiveness of childhood screening for type 1 diabetes: Examining reducing Diabetic Ketoacidosis at diagnosis and long-term outcomes to assess the justifiable cost per child screened.

    Article • NIHR Open Research, September 2025, National Institute for Health Research

    Mr Daniel J Pollard

  6. Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohorts

    Article • Diabetes Obesity and Metabolism, June 2025, Wiley

    Mr Daniel J Pollard

  7. Assessing the value for money, from a policy maker perspective, of 24 randomised controlled trial designs for an online weight maintenance guided self-help intervention: an expected value of sample information analysis

    Article • International Journal of Obesity, May 2025, Springer Science + Business Media

    Mr Daniel J Pollard

  8. A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi‐centre randomised control trial (MiFoot study)

    Article • Diabetic Medicine, April 2025, Wiley

    Mr Daniel J Pollard

  9. A model based cost-utility analysis of Embedding referral to structured self-management education into standard practice (Embedding) compared to usual care for people with type 2 diabetes diagnosis in the last 12 months in England

    Article • BMJ Open, February 2025, BMJ

    Mr Daniel J Pollard

  10. Increasing uptake of self-management education programmes for type 2 diabetes in primary care: the Embedding research programme including an RCT

    Article • Programme Grants for Applied Research, February 2025, National Institute for Health Research

    Mr Daniel J Pollard

  11. Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagno...

    Article • Diabetologia, January 2025, Springer Science + Business Media

    Mr Daniel J Pollard

  12. Assessing the value for money, from a policy maker prospective, of 24 randomised controlled trial designs for an online weight maintenance guided self-help intervention: An expected value of sample information analysis.

    Article • October 2024, Springer Science + Business Media

    Mr Daniel J Pollard

  13. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review

    Article • Advances in Therapy, June 2024, Springer Science + Business Media

    Mr Daniel J Pollard

  14. Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes: an economic evaluation of the 48-month PROPELS randomized controlled trial

    Article • BMJ Open Diabetes Research & Care, March 2024, BMJ

    Mr Daniel J Pollard

  15. Estimation of HbA1c after weight loss using a beta-regression for an economic evaluation of a behavioural weight management programme from the GLoW trial: a methodological study

    Article • The Lancet, November 2023, Elsevier

    Mr Daniel J Pollard

  16. Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: The Hypo-METRICS app

    Article • PLOS One, March 2023, PLOS

    Mr Daniel J Pollard

  17. 233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

    Article • Diabetes, June 2022, American Diabetes Association

    Mr Daniel J Pollard

  18. Hypo‐METRICS : Hypoglycaemia – MEasurement , ThResholds and ImpaCtS – A multi‐country clinical study to define the optimal t...

    Article • Diabetic Medicine, May 2022, Wiley

    Mr Daniel J Pollard

  19. Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application

    Article • BMJ Open, February 2022, BMJ

    Mr Daniel J Pollard

  20. An economic evaluation of triage tools for patients with suspected severe injuries in England

    Article • BMC Emergency Medicine, January 2022, Springer Science + Business Media

    Mr Daniel J Pollard

  21. Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge

    Article • Medical Decision Making, December 2021, SAGE Publications

    Mr Daniel J Pollard

  22. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT

    Article • Health Technology Assessment, December 2021, National Institute for Health Research

    Mr Daniel J Pollard

  23. Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial

    Article • BMC Medicine, June 2021, Springer Science + Business Media

    Mr Daniel J Pollard

  24. An Economic Evaluation of Triage Tools For Patients With Suspected Severe Injuries In England

    Article • May 2021, Research Square

    Mr Daniel J Pollard

  25. Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop

    Article • BMC Health Services Research, May 2021, Springer Science + Business Media

    Mr Daniel J Pollard

  26. Protocol for a cluster randomised controlled trial of the DAFNEplus (Dose Adjustment For Normal Eating) intervention compared with 5x1 DAFNE: a lifelong approach to promote effective self-management in adults with type 1 diabetes

    Article • BMJ Open, January 2021, BMJ

    Mr Daniel J Pollard, Emeritus Professor Mike Campbell

  27. Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge

    Article • Value in Health, September 2020, Elsevier

    Mr Daniel J Pollard

  28. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review

    Article • Health Technology Assessment, June 2020, National Institute for Health Research

    Mr Daniel J Pollard

  29. Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis

    Article • BMJ Open Diabetes Research & Care, April 2020, BMJ

    Mr Daniel J Pollard

  30. Systematic review and meta‐analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes

    Article • Diabetic Medicine, March 2020, Wiley

    Mr Daniel J Pollard

  31. PDB28 A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE

    Article • Value in Health, November 2019, Elsevier

    Mr Daniel J Pollard

  32. PDB65 PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT

    Article • Value in Health, November 2019, Elsevier

    Mr Daniel J Pollard

  33. Systematic Review and Meta-Analysis of Randomised Controlled Trials of Psychological Interventions to Improve Glycaemic Control in Adults with Type 2 Diabetes

    Article • SSRN Electronic Journal, January 2019, Elsevier

    Mr Daniel J Pollard

  34. Systematic Review and Meta-Analysis of Randomised Controlled Trials of Psychological Interventions to Improve Glycaemic Control in Children and Adults with Type 1 Diabetes

    Article • SSRN Electronic Journal, January 2019, Elsevier

    Mr Daniel J Pollard

  35. Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    Article • PharmacoEconomics, September 2018, Springer Science + Business Media

    Mr Daniel J Pollard

  36. Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modelling

    Article • Health Technology Assessment, August 2018, National Institute for Health Research

    Steve Goodacre, Mr Daniel J Pollard

  37. Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

    Article • Value in Health, June 2018, Elsevier

    Mr Daniel J Pollard

  38. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) ra...

    Article • BMJ Open, April 2018, BMJ

    Mr Daniel J Pollard

  39. 10 Decision analysis modelling of diagnostic strategies for suspected pulmonary embolism in pregnancy: the DiPEP economic evaluation

    Article • Emergency Medicine Journal, November 2017, BMJ

    Mr Daniel J Pollard

  40. Expected Value of Sample Information For Individual Level Simulation Models To Inform Stop/Go Decision Making By Public Research Funders: A Methodology for The Dafneplus Diabetes Education Cluster Rct

    Article • Value in Health, October 2017, Elsevier

    Mr Daniel J Pollard

  41. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial

    Article • Health Technology Assessment, April 2017, National Institute for Health Research

    Emeritus Professor Mike Campbell, Mr Daniel J Pollard

  42. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)

    Article • BMJ, March 2017, BMJ

    Emeritus Professor Mike Campbell, Mr Daniel J Pollard

  43. COST-EFFECTIVENESS OF STRUCTURED EDUCATION IN CHILDREN WITH TYPE-1 DIABETES MELLITUS

    Article • International Journal of Technology Assessment in Health Care, January 2016, Cambridge University Press

    Mr Daniel J Pollard

  44. Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    Article • PharmacoEconomics, December 2015, Springer Science + Business Media

    Mr Daniel J Pollard

  45. The cost-effectiveness of the KIds in control of food structured education programme for adolescents with type 1 diabetes

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Mr Daniel J Pollard

  46. Including Psychology in Health Economic Models

    Article • Medical Decision Making, September 2015, SAGE Publications

    Mr Daniel J Pollard

  47. The Potential Value of Ongoing Support In Type-1 Diabetes Mellitus With Dafneplus: Exploratory Pre-Trial Cost-Effectiveness Analysis On Proposed Trial End-Point Target For 12-Month Hba1c Improvement

    Article • Value in Health, November 2014, Elsevier

    Emeritus Professor Mike Campbell, Mr Daniel J Pollard